C83.51
Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck
Clinical Classification Guidelines
Medical Intelligence & Overview
Lymphoblastic lymphoma is a rare type of non-Hodgkin lymphoma characterized by the rapid growth of abnormal lymphoid cells. Specifically affecting the lymph nodes in the head, face, and neck, this condition is considered aggressive and requires prompt medical attention. It mostly occurs in adolescents and young adults, although it can affect individuals of any age. Recognizing the symptoms and understanding the causes can aid in timely diagnosis and treatment planning.
Causes & Symptoms
Clinical Causes: Genetic mutations within lymphoid cells that lead to uncontrolled growth Previous exposure to certain chemicals or radiation Weakened immune system due to illnesses or immunosuppressive treatment Family history of lymphoproliferative disorders Certain infections, such as Epstein-Barr virus (EBV), may play a role Environmental factors that increase risk, although specific causes are often unclear
Key Symptoms: Swelling or lump in the neck, face, or jaw Painless swelling that can grow quickly over days to weeks Facial or neck pain or pressure sensation Difficulty swallowing or breathing in advanced cases Unexplained weight loss Persistent fever or night sweats Fatigue or weakness Enlargement of other lymph nodes in the body
Diagnostic & Treatment
Diagnosis Path: Physical examination focusing on swollen lymph nodes and other signs Imaging studies such as CT scans, PET scans, and MRI to identify affected areas and assess spread Biopsy of an enlarged lymph node or affected tissue to examine cell type and morphology Laboratory tests including blood counts and markers for infection and organ function Immunophenotyping and molecular studies to differentiate lymphoblastic lymphoma from other lymphomas
Treatment Protocols: Combination chemotherapy often forms the mainstay, involving multiple drug protocols tailored to individual patient needs Targeted therapies or immunotherapy may be considered in some cases Radiation therapy to affected lymph node regions, especially if bulky disease or residual disease remains Stem cell transplant might be an option for relapsed or refractory cases Supportive care to manage side effects of treatment and maintain overall health
Clinical Advice & FAQs
Billing Guidance
Is C83.51 a billable ICD-10 code?
Yes, C83.51 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.51?
Clinical documentation must specify the nature of Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck and any associated comorbidities for accurate reporting.
Cite this Clinical Reference